Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01012115 · ClinicalTrials.gov registry record
Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis
A clinical trial of Sepsis, sponsored by University of Oklahoma.
- Completed
- Registry status
- 500
- Enrollment target
- 2
- Study locations
NCT01012115 is a study of Sepsis that has completed, run by University of Oklahoma. The registered enrollment target is 500 participants, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01012115, a study of Sepsis, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
In an effort to better understand the interaction between the different mediators, the investigators propose to examine the time course of mediators, the indexes of organ injury and the coagulation cascade.
Conditions Studied
Study Locations (2)
Oklahoma
- OU Medical Center - Oklahoma City
- Veterans Affairs Medical Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01012115
The ClinicalTrials.gov registry entry for NCT01012115 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (92% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sepsis appearing as the primary indexed condition, and to 0 interventions.
NCT01012115 reports 2 study locations spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01012115 about?
NCT01012115 is a clinical study titled "Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis". In an effort to better understand the interaction between the different mediators, the investigators propose to examine the time course of mediators, the indexes of organ injury and the coagulation cascade.
What is the current status of trial NCT01012115?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2009-10. Estimated completion is 2011-09.
What conditions does trial NCT01012115 study?
This clinical trial studies the following conditions: Sepsis.
Who is sponsoring clinical trial NCT01012115?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01012115 being conducted?
This trial has 2 study locations across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.